Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jan 2006
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium fluoride f-18, fludeoxyglucose f 18 in breast cancer, prostate cancer (PCa), bone metastasis, sponsored by Stanford University. Started Jan 2006; status: completed.
02
Drugs
sodium fluoride f-18fludeoxyglucose f 18
03
Conditions
breast cancerprostate cancer (PCa)bone metastasis
Beyond the preview
Go deeper on NCT00375830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375830.